✦ LIBER ✦

Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency disease

✍ Scribed by Jolles, Stephen; Borte, Michael; Nelson, Robert P.; Rojavin, Mikhail; Bexon, Martin; Lawo, John-Philip; Wasserman, Richard L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, Tolerability, and Efficacy of Hi

✍ Nelson, R.P.; Melamed, I.; Stein, M.R.; Wasserman, R.L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Safety, Tolerability, and Efficacy Of Hi

✍ Imai, Kohsuke; Kanegane, Hirokazu; Yamada, Masafumi; Takada, Hidetoshi; Ariga, T 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Long-Term Efficacy and Tolerability of 2

✍ Borte, Michael; Wasserman, Richard L.; Rojavin, Mikhail; Bexon, Martin; Jolles, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Safety and Efficacy Of Biweekly Hizentra

✍ Malcolmson, Clare; Jones, Alison 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Long-Term Safety, Tolerability, and Effi

✍ Philip J. Mease; I. Jon Russell; Daniel K. Kajdasz; Curtis G. Wiltse; Michael J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Efficacy and Safety of Hizentra®, a New

✍ Michael Borte; Malgorzata Pac; Margit Serban; Teresa Gonzalez-Quevedo; Bodo Grim 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 182 KB